StonvexLoading…
StonvexStonvexStonvexCore line items from MBRX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
Operating Income | $-7.87M | $-25.10M | $-17.57M | $-11.66M |
Net Income | $-12.85M | $-33.56M | $-49.11M | $-23.71M |
EPS (Diluted) | $-3.54 | $-28.42 | $-2.36 | $-1.90 |
Total Assets | $23.36M | $22.13M | $20.35M | $21.59M |
Total Liabilities | $8.18M | $7.12M | $47.27M | $25.18M |
Cash & Equivalents | $10.32M | $8.88M | $6.70M | $7.56M |
Free Cash Flow OCF − CapEx | Not available | $-22.73M | $-17.37M | $-10.15M |
Shares Outstanding | 5.34M | 3.20M | 49.50M | 30.21M |